PlainRecalls

Biocon Pharma INC

Compiled from official public sources by the publisher.

2 recalls on record · Latest: Apr 9, 2025

Subscribe to new Biocon Pharma INC recalls (RSS)

Agency notice ledger

Federal filing book Biocon Pharma INC LIGHT-BOOK · SINGLE-AGENCY

#4,430 of 14,151 · 2 notices · 0.002% archive

  • BOOK 2 notices
  • RANK #4,430 of 14,151
  • SHARE 0.002% archive
  • AGENCY FDA Drug (2)
  • CAT children
  • CATS 1 category
  • LATEST Apr 9, 2025
  • PHOTO 3M Company

Nearest notice-volume peer: 3M Company (0 notice gap)

Biocon Pharma INC accounts for about 0.002% of the 104,423-notice archive on 2 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Biocon Pharma INC's standing among 14,151 recalling firms

Biocon Pharma INC ranks 4,430th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Biocon Pharma INC vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

2 4430th of 14151 higher than 8,037 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-14

Biocon Pharma INC in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Biocon Pharma INC holds about 0.002% of archive notices alongside 2 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Apr 9, 2025

Atorvastatin Calcium Tablets USP 40 mg, 1000-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009 USA, Manufactured by: Recipharm Pharmaservices PVT, Ltd Bengaluru, INDIA -562-123, NDC 70377-079-13
FDA Drug Moderate Feb 15, 2023

Posaconazole Delayed-Release Tablets, 100 mg, 60-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009; Manufactured by: Biocon Pharma Limited, Bengaluru, India - 560 099, NDC 70377-038-11.

Biocon Pharma INC is a small archive contributor

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar children volume

Nearest multi-notice firms in the same narrow category lane.

Adam's Polishes LLC 2 Alliance Chemical, of Taylor, Texas 2 Anatox Inc 2 Aqua Filter Fresh, Inc. 2

Frequently Asked Questions

How many federal recall notices name Biocon Pharma INC? ▼
PlainRecalls indexes 2 distinct federal recall events naming Biocon Pharma INC, aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Biocon Pharma INC sit among other recalling firms? ▼
Biocon Pharma INC ranks #4,430 of 14,151 by distinct recall-event count among 14,151 firms in this archive (57th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Biocon Pharma INC's notices? ▼
FDA Drug accounts for 2 of this firm's 2 indexed notices.
What product category dominates Biocon Pharma INC's filing book? ▼
Filings for Biocon Pharma INC span 1 product category, led by children. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Biocon Pharma INC: 2 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Biocon Pharma INC; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026